• Buy PE-22-28 10mgBuy PE-22-28 10mg Quick View
    • Buy PE-22-28 10mgBuy PE-22-28 10mg Quick View
    • Buy PE-22-28 10mg

    • 97.75AUD
    • Buy PE-22-28 10mg Researched Benefits: Selective TREK-1 potassium channel antagonist for investigating antidepressant-like signaling pathways Facilitates analysis of hippocampal brain-derived neurotrophic factor expression and activation Supports research on glutamatergic neurotransmission modulation and synaptic plasticity in assays Enables evaluation of rapid-acting neurogenic responses within controlled cellular assay models
    • Add to cart